Cargando…
Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer
Targeted tumor and efficient, specific biological drug delivery in vivo has been one of the main challenges in protein-based cancer-targeted therapies. Mitochondria are potential therapeutic targets for various anti-cancer drugs. We have previously reported that protein kinase Cα-mediated phosphoryl...
Autores principales: | Kim, Jae-Sung, Lee, Daeun, Kim, Donggyu, Mun, Seok-Jun, Cho, Euni, Son, Wooic, Yang, Chul-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967779/ https://www.ncbi.nlm.nih.gov/pubmed/32002124 http://dx.doi.org/10.18632/oncotarget.27417 |
Ejemplares similares
-
Toxoplasma gondii GRA9 Regulates the Activation of NLRP3 Inflammasome to Exert Anti-Septic Effects in Mice
por: Kim, Jae-Sung, et al.
Publicado: (2020) -
Mycobacterium tuberculosis Rv2626c‐derived peptide as a therapeutic agent for sepsis
por: Kim, Sun Young, et al.
Publicado: (2020) -
Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice
por: Sun, Hong-chao, et al.
Publicado: (2023) -
Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli
por: Babaie, Jalal, et al.
Publicado: (2011) -
Development and evaluation of recombinant GRA8 protein for the serodiagnosis of Toxoplasma gondii infection in goats
por: Jirapattharasate, Charoonluk, et al.
Publicado: (2021)